Independent Research Analysis Developed for the Client
Both Timely & Relevant to Enable Strategic Business Decisions.
Research Analysts have struggled with traditional investment banks because of the conflict of interest with the firms buy side clients and the investment bankers. We do produce the highest quality research. We do Not make Recommendations. We don’t have target prices. We analyze risk and reward. Understood is that we look for 2 units of upside for every Unit of downside in the risk reward exercise. We are not engaging in “Beauty Contests”. We have no “Book” to protect. We can bring multiple disciplines to bear for the benefit of clients. There’s no compulsion to “Publish or Perish”. Our analysts work for you.
Providing Relevant Insight to Institutional Clients.
Short overview of what they should expect to receive and why they should be purchasing this product. Talk to the key pain points of your consumer base and explain how purchasing your product will solve for this issue.
Norm Kumar, CFA
Senior Analyst, Technology & Healthcare
Norm has over 20 years of investment experience in both private and public equity. Presently, he is a Senior Healthcare & Technology Analyst for the Pennock Idea Hub. At PIH, he provides independent research to Institutional clients on topics within the healthcare and technology spheres covering individual stocks as well as writing about emerging technologies such as AI and a soon to be released report on CRISPR. We not only generate our own ideas but produce bespoke research for clients to assist them in analyzing situations of interest. Norm also works with the White Owl family office to assist them in assessing potential private equity investments within the healthcare field, particularly drug and device companies. Prior to PIH, Norm served as a Sr Investment Consultant to XPV Water Partners where he assisted them in deal analysis and execution for their existing portfolio and new investments. Earlier in his career, he was a Portfolio Manager and CIO at two hedge funds, Radiant & K2, with primary responsibility for the healthcare and technology investments. Additionally, he was a senior investment professional at two prominent Canadian Venture Capital/Private Equity funds (CIBC Capital Partners and Working Ventures Canadian Fund) where he had responsibility for direct investments. He has served on numerous Boards over the years. Norm tries to bring the discipline of private equity analysis to public market investment assessments to assist clients to make meaningful risk-reward decisions.
To Get All the Latest Market Updates.